thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA (NCH2.DE) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for thyssenkrupp nucera AG & Co. KGaA (NCH2.DE), covering cash flow, earnings, and balance sheets.
thyssenkrupp nucera AG & Co. KGaA (NCH2.DE) Income Statement & Financial Overview
Access detailed annual and quarterly income data for thyssenkrupp nucera AG & Co. KGaA NCH2.DE financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $262.00M | $250.00M | $235.70M | $168.00M |
| Cost of Revenue | $233.00M | $221.70M | $211.60M | $151.80M |
| Gross Profit | $29.00M | $28.30M | $24.10M | $16.20M |
| Gross Profit Ratio | $0.11 | $0.11 | $0.10 | $0.10 |
| R&D Expenses | $7.00M | $10.90M | $10.50M | $9.20M |
| SG&A Expenses | $18.00M | $21.40M | $18.70M | $20.10M |
| Operating Expenses | $24.00M | $28.30M | $29.20M | $29.30M |
| Total Costs & Expenses | $257.00M | $250.00M | $240.80M | $181.10M |
| Interest Income | $7.00M | $5.00M | $7.40M | $7.10M |
| Interest Expense | $2.00M | -$2.20M | $500000.00 | $1.00M |
| Depreciation & Amortization | $3.00M | $2.00M | $1.20M | $1.50M |
| EBITDA | $16.00M | $3.70M | $2.00M | -$2.00M |
| EBITDA Ratio | $0.06 | $0.01 | $0.008 | -$0.01 |
| Operating Income | $5.00M | $0.00 | -$5.10M | -$13.10M |
| Operating Income Ratio | $0.02 | $0.00 | -$0.02 | -$0.08 |
| Other Income/Expenses (Net) | $8.00M | $3.90M | $12.70M | $8.60M |
| Income Before Tax | $13.00M | $3.90M | $7.60M | -$4.50M |
| Income Before Tax Ratio | $0.05 | $0.02 | $0.03 | -$0.03 |
| Income Tax Expense | $4.00M | -$5.70M | $1.80M | $2.80M |
| Net Income | $9.00M | $9.60M | $5.80M | -$7.20M |
| Net Income Ratio | $0.03 | $0.04 | $0.02 | -$0.04 |
| EPS | $0.07 | $0.08 | $0.05 | -$0.06 |
| Diluted EPS | $0.07 | $0.08 | $0.05 | -$0.06 |
| Weighted Avg Shares Outstanding | $126.00M | $126.00M | $126.30M | $126.30M |
| Weighted Avg Shares Outstanding (Diluted) | $126.00M | $126.00M | $126.30M | $126.30M |
The company's financials show resilient growth, with revenue advancing from $168.00M in Q2 2024 to $262.00M in Q1 2025. Gross profit remained healthy with margins at 11% in Q1 2025 compared to 10% in Q2 2024. Operating income hit $5.00M last quarter, sustaining a consistent 2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $16.00M. Net income dropped to $9.00M, while earnings per share reached $0.07. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan